biopharma

R&D

Allogeneic therapies: The future of cancer treatment?

As autologous cancer therapies have advanced and shown incredible efficacy, the industry is looking for the next step for this type of treatment.

News

Changing Faces: Biopharma hires from Dec. 2022 and Jan. 2023

Because of the holidays and the hustle and bustle around JP Morgan, we’re wrapping up our hires roundups from December and January into three double issues – stay tuned for other roundups f

R&D

How pharma can incorporate AI into research

The use of artificial intelligence (AI) in the biopharma industry has the potential to revolutionise drug discovery and development, as well as improve patient care.

News